1. Home
  2. BMR vs FEMY Comparison

BMR vs FEMY Comparison

Compare BMR & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beamr Imaging Ltd.

BMR

Beamr Imaging Ltd.

N/A

Current Price

$1.28

Market Cap

19.3M

Sector

Technology

ML Signal

N/A

FEMY

Femasys Inc.

N/A

Current Price

$2.10

Market Cap

22.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BMR
FEMY
Founded
2009
2004
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.3M
22.4M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
BMR
FEMY
Price
$1.28
$2.10
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $14.33
AVG Volume (30 Days)
26.4K
★ 67.0K
Earning Date
08-11-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 44.71
EPS
★ N/A
N/A
Revenue
N/A
★ $2,293,313.00
Revenue This Year
$0.19
N/A
Revenue Next Year
N/A
$328.45
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 40.77
52 Week Low
$1.06
$0.29
52 Week High
$3.24
$6.29

Technical Indicators

Market Signals
Indicator
BMR
FEMY
Relative Strength Index (RSI) N/A 37.40
Support Level N/A $0.41
Resistance Level N/A $3.21
Average True Range (ATR) 0.00 0.17
MACD 0.00 -0.04
Stochastic Oscillator 0.00 27.12

Price Performance

Historical Comparison
BMR
FEMY

About BMR Beamr Imaging Ltd.

Beamr Imaging Ltd provides content-adaptive video compression solutions for human viewing and machine vision. The company is trusted by technology companies such as NVIDIA and Amazon Web Services, and serves media companies including Netflix, Paramount, and JioHotstar. Using Emmy-winning patented technology, its solutions help deliver media content with high quality while reducing storage and delivery costs. Its customers include over-the-top content distributors, video streaming platforms, and Hollywood studios that use its products to store, distribute, and monetize video and images across devices. The company operates in the United States, Israel, and the rest of the world, with the United States generating maximum revenue.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: